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GENETIC TESTING IN THE WORKPLACE
INTRODUCTION
Occupational disease is a pervasive problem in our society. It is estimated
that 390,000 workers contract disabling illnesses each year, and approxi-
mately 100,000 die from these occupational diseases.' Statistics demonstrate
that exposure to chemicals used or produced in the workplace is the predom-
inant cause of occupational health problems, primarily because of the
number of workers involved.2 As these and other alarming facts concerning
occupational health have been made available, investigations and debates
have arisen concerning how such diseases can be minimized. One of the
most controversial methods is the use of genetic testing in the workplace.
Genetic tests can identify so called "hypersusceptible" workers; persons
who either inherited or, through chemical exposure, acquired "defective"
genes creating a vulnerability to certain occupational illnesses.' While ge-
netic testing may provide health benefits to many employees, its use as a
1. Palisano, Will the Gene Screen Revolutionize Occupational Medicine?, OCCUPATIONAL
HAZARDS, Oct., 1986, at 67.
2. Office of Technology Assessment, ROLE OF GENETIC TESTING IN THE PREVENTION
OF OCCUPATIONAL DISEASE 24 (1983) [hereinafter OTA Report]. It is estimated that 8.5
million workers per year are exposed to chemical hazards in the manufacturing industry. Fur-
thermore, particular jobs expose workers to numerous chemicals. For example, the OTA Re-
port states that rubber workers are exposed to approximately 3,000 chemicals. Id.
3. The medical definition of a hypersusceptible individual is: a condition of inordinate or
abnormally increased susceptibility to chemicals, infective agents, or other agents which in the
normal individual are entirely innocuous... workers who react to certain substances at low
levels, below the threshold concentration associated with injury or definite discomfort. (cita-
tions omitted). Reinhardt, Chemical Hypersusceptibility 20 J. OCCUPATIONAL MED. 319 (May
1978). See also Samuels, Medical Surveillance: Biological, Social and Ethical Parameters, 28 J.
OCCUPATIONAL MED. 572, 574 (1986) (emphasizing that the different reactions of workers is
due to a combination of what they inherit and the environment to which they are exposed.)
Of the more than 55,000 different chemicals available for use in the workplace, there are no
estimates indicating what percenatge of these are hazardous to employee health. OTA Report,
supra note 2, at 24. However, numerous substances are believed to have a correlation to occu-
pational diseases. Below are some examples of genetic traits and the resulting illnesses for
susceptible workers who have been exposed to certain chemical agents. Most of these charac-
teristics have been the focus of genetic screening in the past.
1. Glucose-6-phosphate dehydrogenase (G-6-PD) Deficiency
G-6-PD deficiency has been a common subject of genetic screening. In fact, it was the
second most frequently tested trait of the 366 companies responding to the OTA
survey. OTA Report, supra note 2, at 34. It is a sex-linked condition affecting males.
When exposed to certain oxidizing chemicals a worker with the deficiency suffers a
hemolytic crisis, or a deterioration of the red blood cells resulting in anemia. Hear-
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screening device can also create serious consequences. The potential for dis-
ings, infra note 23, at 159. Other substances which could trigger hemolytic effects
are copper, TNT, and ozone. OTA Report, supra note 2, at 90-91.
While the sex of a worker is an important criteria in testing for this type of defi-
ciency, ethnic background is also relevant. There are variants of the G-6-PD defi-
ciency found in black and Mediterranean populations resulting in some of the most
serious hemolytic effects. Although the variants found in these populations are the
most severe, several other variants of the G-6-PD trait exist, depending upon gep-
graphical location. Furthermore, the frequency of this trait is highest in American
blacks at approximately 13-16%; in Filipinos at 12-13%; in Mediterranean Jews at
11%; in Greeks at 2% to 32%; in Scandinavians at 1% to 8; in Chinese at 2 to 5%;
in European Jews at 1%; in East Indians at 0.3%; and in the American and British
Caucasians at 0.1%. Id. at 90.
The evidence accumulated in past studies reflects a strong correlation between the
G-6-PD deficiency and occupational exposure as the cause of illness. Nevertheless,
many of these observations have been made in vitro, thus requiring further research
under actual exposure situaitons. Id. at 90-91.
2. Sickle-cell Trait
The trait found in black populations that can eventually lead to the disease sickle-cell
anemia has been the most debated of the genetic susceptibilities. There are four ob-
stensible reasons for the controversies. First, because it predominantly affects blacks
(the trait can also exist in some Mediterranean populations), there exists a heightened
concern for racial discrimination. Second, despite the lack of evidence proving that
sickle-cell anemia is triggered by chemical exposures, Omenn, Predictive Identifica-
tion of Hypersusceptible Individuals, 24 J. OCCUPATIONAL MED. 369, 372 (1982), a
survey of major industries revealed that the majority of occupational genetic screen-
ing has been for the sickle-cell trait. OTA Report, supra note 2, at 91. Third, many
confuse the trait with the disease, even though persons possessing the sickle-cell trait
may never experience the effects of sickle-cell anemia. Id. Finally, if an individual
were to possess the genetic condition, it would become active during one's childhood
and, at that time, may be made known to the carrier. This eliminates the need for it
to be detected through preemployment screening tests. Id.
Consequently, the use of employment tests for determining the existence of the
sickle-cell trait should be conducted for genetic counseling purposes only, i.e., a per-
son known to be carrying the trait should be provided guidance in decisions concern-
ing reproduction. Omenn, supra, at 372. There also have been suggestions that
employers should simply cease sickle-cell trait testing, making it the responsibility of
the community and the individual. See, Hearings, infra note 23, at 160 (statement of
Gilbert S. Omenn, M.D., Ph.D.).
3. Thalassemiac Trait
Thalassemiac is an erythroblastic anemia - a deficiency in the production of red
blood cells. An individual may possess the trait in either a heterozygous of homozy-
gous form, thus suffering from the disease in a mild to fatal degree, respectively.
However, the heterozygous form has a higher frequency and is more difficult to de-
tect. Additionally, even in its mild state, the disease can be exacerbated under in-
creased exposure to occupational chemicals. Research is being carried out to
evaluate these effects from benzene and lead exposures. Variants of the thalassemia
heterozygous trait occur in American blacks at 2-7%; in Greek-Americans and Ital-
ian-Americans at 4-5%; and in others of Greek ancestry at 2%. OTA Report, supra
note 2, at 90-92.
4. NADH Dehydrogenase Deficiency
In order for oxygen to be transported to the body tissues, it must bind itself to red
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criminatory testing, or discriminatory use of the results, is at the forefront of
the debate because genetic traits are often directly related to a person's racial
or ethnic background. Thus, there are fears that the technology could be
used to exclude from the workplace persons of particular racial or ethnic
groups due to an assumption that they possess genetic vulnerability.
The exclusion of genetically vulnerable employees can also have deleteri-
ous effects on their less susceptible co-workers. Hypersusceptible workers
actually play an important role in warning employers that a serious health
hazard exists. If susceptible workers are removed, occupational dangers to
other workers could go unnoticed or concealed. As a result, employees who
did not demonstrate having the genetic variation may contract the same ill-
ness years later. This is not to suggest that hypersusceptible employees
should be placed at risk for the sake of protecting less susceptible employees.
Rather, if the tests are used, they should operate to protect both categories of
workers by informing susceptible workers that they may be at a greater risk
of contracting an occupational disease, and by providing notice that a poten-
tial risk to other employees may exist.
The benefits from this rapidly developing technology are accompanied by
a penumbra of legal, ethical and social implications. Although the tests are
still in relatively early stages of development, they have already been used in
the workplace.4 Therefore, there is an urgency to address the legal and ethi-
cal ramifications of this use of genetic testing so that guidelines and regula-
blood cells. This involves the oxidation of the iron atom in the red blood cells. Nor-
mally, once the oxygen is released, the hemoglobin returns to its unoxidized state.
However, when this does not occur, often due to a NADH dehydrogenase deficiency,
methemoglobinemia results. The exact effects of this disease vary with its severity,
but it can include bluish skin, headaches, shortness of breath, lethargy and even
death. Methemoglobinemia can be aquired from chemical exposure to aromatic ni-
tro and amino compounds. Populations demonstrating a greater susceptibility to the
NADH dehydrogenase deficiency include Alaskan Eskimos and Indians, Navajo In-
dians and Puerto Ricans. Id. at 92.
Although screening for this trait in an occupational setting has not been con-
ducted, studies indicating the connection between industrial chemical exposures and
methemoglobinemia suggest that a number of employees could be at serious risk. Id.
at 93. Thus, it is reasonable for the NADH dehydrogenase deficiency to be a suitable
target for genetic testing in the workplace.
5. Skin Hypersensitivities
Seventy percent of all occupational disease claims paid by insurance companies are
for industrial dermatitis. Hearings, infra note 23, at 161 (statement of Gilbert S.
Omenn, A.D., Ph.D.). There is a wide range of skin reactions to various chemicals.
Many suggest that the differences experienced to dermatologic irritants could be ge-
netically linked. Id. However, studies have not yet identified a specific causative
trait. OTA Report, supra note 2, at 98. Because dermatitis is so prevalent under
varying occupational conditions, further research into its genetic causes is warranted.
4. See infra note 12.
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tions may be developed to balance the competing interests of both the
employer and the employee.
This Comment reviews the existing methods of genetic testing of workers
and the purposes for which they are used. Genetic screening, rather than
genetic monitoring, shall be the main focus of this Comment because the
past and potential future use of genetic screening exceeds that of genetic
monitoring. The legal, social and ethical dilemmas relevant to this emerging
controversial technology will be explored.5 In particular, this Comment ex-
amines the employer's duties to provide a safe working environment, the
employee's rights implicated by genetic testing, and the statutory sources
that are available to regulate this potentially invasive and explosive area of
genetics. Finally, this Comment looks at the future of genetic testing and the
proposals being made as to how it should be managed in order to protect the
competing interests involved.
OVERVIEW OF GENETIC TESTING
Development of a New Technology
It has been over twenty years since the notion of identifying workers' ge-
netic susceptibilities to industrial chemicals was first suggested.6 The idea
represented a response to correlations observed between the science of genet-
ics and occupational health. Researchers had learned that the susceptibili-
ties to chemical exposures varied significantly between individual workers.7
They also discovered that even where exposure levels at a particular work-
place were well below the required standards, hypersusceptible workers ex-
perienced adverse reactions.8 Finally, developments made in human
genetics led to the theory that such susceptibilities were linked to an individ-
ual's genetic makeup.9
With the identification of a new "susceptible working class" and the ad-
5. Because this Comment addresses genetic testing in private companies with only brief
mention of testing conducted by the Government, the possible constitutional issues will not be
discussed.
6. See Stokinger & Scheel, Hypersusceptibility and Genetic Problems in Occupational
Medicine - A Consensus Report, 15 J. OCCUPATIONAL MED. 564 (1973). See also PRESIDENT'S
COMMISSION FOR THE STUDY OF ETHICAL PROBLEMS IN MEDICINE AND BIOMEDICAL AND
BEHAVIORAL RESEARCH, SCREENING AND COUNSELING FOR GENETIC CONDITIONS: A RE-
PORT ON THE ETHICAL, SOCIAL AND LEGAL IMPLICATIONS OF GENETIC SCREENING, COUN-
SELING AND EDUCATION PROGRAMS 11-12 (Feb. 1983) [hereinafter President's Commission].
See generally G. SMITH, GENETICS, ETHICS AND THE LAW (1981); Smith, Genetics, Eugenics
and Public Policy, 1986 So. ILL. L. REV. 435.




vent of genetic tests, prerequisites for occupational hypersusceptibility tests
were eventually devised. These guidelines include: 1) the detection of a spe-
cific genetic anomaly, 2) a high prevalence of the anomaly in the worker
population, 3) the substances affecting the genetic traits should be common
to the industry, 4) the trait must be otherwise compatible with one's normal
lifestyle until industrial exposure occurs, and 5) the test must be relatively
inexpensive and simple, thus available for large scale use."°
Since that time, tests have been improved" and relied upon by various
manufacturing companies and utilities for both medical practice and re-
search purposes. 12 In more recent years, however, companies once enthusi-
astic about using genetic tests have "gone underground" and are less willing
to publicly announce such practices. This is largely attributable to congres-
sional hearings held in the early 1980's which exposed some of the uncer-
tainties of the scientific validity and legal and social applicability of genetic
testing in the workplace.13
Methods of Genetic Testing
Genetic variability is only one factor contributing to the response an indi-
vidual may have to his environment - his workplace. Other factors, such as
a person's diet or smoking habits, play a role as well.' 4 Thus, genetic testing
is viewed as a possible means for evaluating at least one of the causes of
occupational illness.' 5 Scientists have devised two different methods to
10. Id. at 564-65.
11. See OTA Report, supra note 2, at 26 (genetic testing has potential for use in medical
surveillance because many traits may be identified by easy and inexpensive tests). See also
Genetic Screening of Workers: Hearing Before the Subcomm. on Investigations and Oversight of
the House Comm. on Science and Technology, 97th Cong., 2d Sess. 44 (1982) (statement of
Gretchen Kolsrud, Ph.D., Manager of Biological Applicaitons Progam, Office of Technology
Assessment) (observing that progress in the field of genetics is extraordinary) [hereinafter
Hearings]. See also Otten, Genetic Examination of Workers is an Issue of Growing Urgency,
Wall Street J., Feb 24, 1986, at 1, col. 1 (quoting Marc Lappe, Professor of Health Policy,
University of-California, that "these tests have tremendous predictive power, and that can only
increase.").
12. The OTA Report which summarized the findings of its 1982 survey discovered that,
of the responding 366 organizations, six (1.6%) were currently testing, seventeen (4.6%) used
genetic testing during the previous twelve years, four (1.1%) anticipated using the tests in the
following five years, and 55 (15%) would possibly use the tests in the following five years.
OTA Report, supra note 2, at 34. Furthermore, genetic testing in the workplace has been
implemented in several European countries and no longer is restricted for use in academic
research. See Otten, supra note 11, at 8, col. 4.
13. See Englade, Who's Hired and Who's Fired?, 14 STUDENT LAWYER 20, 27 (1986).
14. OTA Report, supra note 2, at 27.
15. It should not be assumed that genetic testing could be an exclusive remedy to occupa-
tional disease. Indeed, many workers not possessing a genetic deficiency may contract the
same illness at a later date, or they may be prone to certain diseases for different reasons.
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pinpoint illness causing traits: genetic monitoring and genetic screening.
Both the mechanics and the purposes of each method differs. To note,
screening methods have already been utilized by private industries and by
the military. 16
Genetic Monitoring
Genetic monitoring assesses whether an individual has experienced ge-
netic damage as a result of previous exposure to hazardous chemicals or
ionizing radiation. 17 Workers subjected to this type of testing undergo peri-
odic examinations using blood or other body fluids to determine whether any
genetic damage has occurred.'" Monitoring can be done in two ways: cyto-
genetic techniques or noncytogenetic techniques. The former involve the de-
tection of major structural damage in chromosomes.' 9 The latter look for
damage to the molecular structure of the deoxyribonucleic acid ("DNA")
contained within chromosomes.2 ° Cytogenetic techniques remain largely in
the developmental stages.2 '
Once perfected, genetic monitoring could be used to determine whether a
carcinogen is present in the workplace and whether exposure levels to a car-
cinogen present a risk to employee health.22 Such tests can only be per-
formed on groups of workers, not on individuals. Therefore, the tests could
determine if a population of workers is at an increased health risk and
whether the exposure level should be decreased for that group.23 Interest-
ingly, because no single employee's hypersusceptibility can be identified by
Nonetheless, genetic testing can help to focus on what is believed to be a significant factor of
many occupational diseases.
16. The U.S. Air Force previously had a policy of disqualifying candidates who possessed
merely the trait for sickle-cell anemia, a condition primarily affecting blacks. The reason be-
hind the policy was that such persons would suffer a "sickle cell crisis" at high altitudes caus-
ing dizziness and fainting. This policy was followed despite statistics indicating that only
7.4% of those in the Air Force participate in flight duties. See generally Severo, Air Force
Rejects Cadets with Sickle Trait, N.Y. Times, Feb. 4, 1980, at 13, col. 1. The Air Force has
subsequently discontinued the policy. However, the U.S. Coast guard has begun a genetic
montitoring program. See infra text at note 37.
17. OTA Report, supra note 2, at 28.
18. Samuels, Genetic Testing of Workers, A Technical Report to the Executive Council of
the AFL-CIO Industrial Union Department 1 (June 1983) (Unpublished report).




23. Genetic Screening in the Workplace: Hearing Before the Subcomm. on Investigations
and Oversight of the'House Comm. on Science and Technology, 97th Cong., 2d Sess. 159 (1982)
(statement of Geoffrey M. Karney, Project Director, Biological Applications Program, OTA)
[Hereinafter Hearings].
Genetic Testing
these methods, there is less potential for discriminatory employment effects
in comparison to genetic screening methods.24
Genetic Screening
Genetic screening methods are used on an individual, rather than group,
basis. Therefore, genetic screening tests can be administered to individual
applicants or employees.25 By studying a person's body fluids, usually
blood, the test can identify the presence of a specific genetic trait. The trait
may indicate a vulnerability to an occupational illness should the person be
exposed to a particular chemical.26 Unlike genetic monitoring, genetic
screening methods are primarily concerned with the actual possession of the
trait. Therefore, genetic screening ignores whether a person has inherited
this trait or has acquired it through previous exposure.27 Additionally, the
purpose of screening is to prevent hypersusceptible workers from entering
certain jobs in the first place, as opposed to monitoring which indicates ex-
cessive exposure levels.
Genetic screening can be used as an effective exclusionary tool. The
hypersusceptible applicant may not be hired on the basis of the test results,
while a current employee possessing a genetic vulnerability may be prohib-
ited from obtaining a transfer or promotion. 2  However, the fact that an
occupational disease in these individuals may be prevented lends support to
the argument that the benefits outweigh the costs of not entering a poten-
tially hazardous area of work. This will be discussed below at greater length.
It is important for now, however, to be aware that these issues are central to
the debate over the use of genetic screening.
Validity of Genetic Tests
Although genetic tests have already been used to identify both individuals
and groups with particular genetic traits, there still exists a great deal of
discrepancy over their validity and reliability. The validity of a test is de-
24. Id. at 15-16.
25. OTA Report, supra note 2, at 28.
26. Id.
27. Samuels, supra note 18, at 2.
28. The OTA Report noted that, in response to genetic test results, some employers trans-
ferred the hypersensitive workers while others suggested that they seek employment elsewhere.
See, OTA Report, supra note 2, at 37. Where transfers occur, employers should be required to
maintain the employee's status and the rate of pay. Furthermore, suggestions that employees
seek alternative employment should not be made in a coercive manner. It may be necessary to
establish legal protections to safeguard employees from such conduct.
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fined as the degree to which a test measures what it is intended to measure.29
The predictive value of a test depends upon three factors: 1) the test's sensi-
tivity (a measure of the test's accuracy in correctly identifying persons with
the condition), 2) the test's specificity (a measure of the tests accuracy in
correctly identifying persons free of the condition), and 3) the actual fre-
quency of the condition in the population being screened.3° The reliability
of a test refers to the degree to which the test consistently reaches the same
result in any given circumstance. 31 These definitions are important to ge-
netic testing because they establish that a test's objective is to find the line of
demarcation between those testing positive and those testing negative. This
is otherwise known as the "cutoff point.",32 Methods have been devised for
choosing a cutoff point which will enable testers to more accurately identify
workers who possess the genetic trait.33 However, the sensitivity and speci-
ficity are inversely related. Therefore, a test with the ability to achieve high
sensitivity will have low specificity, and one having high specificity will have
low sensitivity.34 It is essential that a proper balance between these two
measurements be established in selecting a cutoff point in order to ensure the
validity of a test. Still, although cutoff points could help obtain accurate test
results, the validity and reliability of genetic testing remains unconfirmed.
One commentator explained that the "scientific legitimacy of genetic analy-
sis is perverted by the rising tendency to isolate and favor it as a sole expla-
nation of disease.. .. ,3- A more prevalent view is that, although the tests
have not sufficiently met scientific criteria for use in an occupational setting,
the significant advances which have been made merit further investigation.36
Nonetheless, as arguments over validity and reliability continue, new pro-
grams using genetic tests are being implemented. For example, the United
29. Diamond, Genetic Testing in Employment Situations, A Question of Worker Rights, 4
J. LEGAL MED. 231, 235 (1983).
30. See, OTA Report, supra note 2, at 57-58; Genetic Screening and the Handling of High
Risk Groups in the Workplace: Hearings Before the Subcomm. on Investigations and Oversight
of the House Comm. on Science and Technology., 97th Cong., 1st Sess. 118-19 (1981) (state-
ment of Paul Rickey, U.S. Public Health Service) [hereinafter Hearings].
31. Diamond, supra note 29, at 235.
32. For example, if the test is established to identify all workers with a genetic defect, it is
likely that these so called "true positives" will be detected. However, it may be overly-inclu-
sive, or non-specific, and therefore result in many "false positives". The effect would be to
label non-susceptible workers as genetically susceptible. Therefore, followup tests must be
conducted to determine which workers actually possess the genetic trait. On the other hand,
where only a certain number of workers are to be identified, some may go undetected, indicat-
ing an under-inclusive test. See OTA Report, supra note 2, at 58.
33. Id.
34. Id.
35. Samuels, supra note 3, at 575.
36. See OTA Report, supra note 2, at 98-99; Hearings, supra note 23, at 161-62.
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States Coast Guard has recently established a genetic monitoring program in
order to analyze exposure data and identify hazardous chemicals.37 In addi-
tion, a 1982 survey of Fortune 500 manufacturing utilities and companies
indicated that several employers were currently using some form of genetic
testing. Others had used them in the past, while a number of other compa-
nies were considering using the tests in the near future. "  Even though the
tests' validity and reliability is currently being questioned, many employers
believe that "some validity" is sufficient to warrant the biological screening
of workers, 39 as evidenced by the fact that some companies have already
used genetic tests in the workplace.
Purposes
Generally, there are four common purposes of genetic testing: diagnosis,
research, information and exclusion.' Each raises its own legal and ethical
considerations. It is the fourth purpose, however, that constitutes the most
controversial due to its potential for discriminatory and coercive effects. Yet,
the possible benefits from all of these purposes can lend legitimacy to argu-
ments in favor of genetic testing, provided that they are accompanied by
proper guidelines and safeguards. With proper guidelines and safeguards,
genetic employment examinations would be more acceptable legally, ethi-
cally and societally.
Diagnosis
In uncovering the causes of an occupational illness, a physician is con-
fronted with an array of possible factors, genetic variances being only one. It
is more beneficial to take an eclectic approach in identifying the etiology of
an illness, rather than attempting to focus on only one or two factors. Thus,
genetic tests are considered important diagnostic aids for many medical in-
quiries.4 Studies show that both the organism itself and the surrounding
environment will influence the impact of a disease. The more difficult task,
however, is to determine the extent to which each plays a role. As genetic
tests are made available for diagnostic purposes, the degree to which genes
37. Field, Biological Monitoring and Genetic Screening in the Industrial Workplace: A
Synopsis and Analysis, 11 LAW, MED. & HEALTH CARE 125, 128 (1983).
38. See supra note 12. It has been suggested that genetic screening is the method more
commonly relied upon by those companies which use genetic testing. See Hearings, supra note
11, at 103 (statement of Mark A. Rothstein, West Virginia University School of Law). One
explanation is that such techniques have a greater predictive value than monitoring techniques.
Id. at 102.
39. See Hearings, supra note 23, at 29 (statement of Congressman Gore).
40. Id. at 82 (statement of Thomas H. Murray, Ph.D., Hastings Center).
41. Id. at 84.
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are causative factors of disease will become more clear. This will add credi-
bility and lessen apprehension to the use of genetic testing.
Specific dilemmas can arise subsequent to the diagnosis that an employee
is genetically predisposed to illness. The employee could be labeled "consti-
tutionally weak" to perform a job, and therefore find difficulty in obtaining
employment. 42 Likewise, past experience warns that the lack of adequate
genetic counseling has led to many patients misunderstanding their condi-
tions.4 3 Consequently, a high degree of care should be observed by physi-
cians when explaining to patients the existence of a genetic anomaly and its
consequences, i.e., what occupations the patient should not enter, family
planning, and what short and long-term effects exist.
Research
Due to current conflicts over the validity of genetic testing, research is
probably the most appropriate use of this infant technology." Unfortu-
nately, research is not a common purpose among those companies that have
conducted the tests.45 There are two specific areas in which research is gen-
uinely needed. First, further epidemiological studies must be conducted to
confirm the connection between populations of workers, workplace exposure
and resulting illnesses. Second, greater inquiry must be made into the effi-
cacy of genetic tests to actually minimize occupational disease. 4  An in-
crease in research of these areas could have a significant impact on the
degree to which genetic tests are considered reliable, valid and necessary.
Research purposes pose important ethical concerns. The most frequently
debated are the issues of confidentiality and informed consent. How and
when they arise often depends upon the relationships existing between the
parties involved. For example, researchers conducting the tests are often the
employer's agents, while the subjects are its employees. Thus, researchers
have a duty to reveal test results to their employers, while owing no duty of
confidentiality to the employees tested. In addition, the benefits from re-
search may not be directed toward the subjects themselves but, rather, to-
42. Id.
43. Id.
44. Id. at 86.
45. The OTA Report cited research as the least frequent use by organizations which re-
sponded to the 1982 survey. OTA Report, supra note 2, at 39. But see APPLICATIONS OF
BIOTECHNOLOGY TO TESTS FOR HUMAN GENETIC DISORDERS, OFFICE OF TECHNOLOGY
ASSESSMENT 28 (July 1986) (unpublished report) (survey of 47 companies developing DNA
probes: 83% stated the probes were for research purposes, while 66% were developing them
for diagnostic purposes) [hereinafter Applications of Biotechnology].
46. Hearings, supra note 23, at 85. (statement of Thomas H. Murray, Ph.D., Hastings
Center).
Genetic Testing
ward employees working under similar conditions at a future date.
Consequently, the importance of an employee's right to confidentiality and
informed consent is lessened by his status as a "non-interested" subject in
the study.47 Finally, because the tests are being used for research and not
exclusionary purposes, and therefore not intended to affect employment, in-
formed consent may not be considered necessary for employee
participation.4"
Traditionally, decisions as to whether informed consent or confidentiality
are required have been the responsibility of the researchers.49 If such prac-
tices continue, it will be necessary to provide researchers with clear guide-
lines addressing the possible legal and ethical effects of their decisions. For
instance, where confidentiality is not maintained, researchers should be
made aware of exactly who will be permitted access to the information and
how this will affect the subject's future employment. Researchers should
also be able to identify under what circumstances and for what purposes
informed consent is desired.
Information
Using genetic test results to provide occupational health information can
be of considerable value to both employees and employers. Employees
would be advised of potential health risks before coming into contact, or
having further contact, with deleterious substances. Employers could not
only be made aware that individual employees or worker populations may be
at risk, but also that certain exposure levels are too high. Furthermore, the
use of genetic test results to improve occupational health is generally disfa-
vored because current test validity is poor.5  The benefit to employers, how-
ever, fuels arguments opposing genetic testing. Its critics assert that the tests
will lead to employment discrimination against a particular racial or ethnic
group that has become associated with a genetic trait.
Once reliability in genetic testing is achieved, the information produced by
the tests could be used to help employees select places of employment. Two
caveats, however, deserve mentioning. First, the consequences and choices
related to genetic susceptibility should be thoroughly explained to an em-
ployee in order to aid future employment decisions. Second, whether a
screening program will be socially desirable depends on the conscionability
of these available choices.51 For example, if one of the choices is to find
47. Id.
48. Id at 86.
49. Id
50. Id at 87.
51. Id. at 88.
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alternative employment, a reasonable number of job opportunities must be
available in order to consider the option conscionable.
Exclusion
Employers have already begun to rely on screening tests in preemploy-
ment situations.52 Due to a lack of guidelines in administering their exclu-
sionary policies, abuses have resulted.53 Because of the inherently
controversial nature of genetic screening, the exclusionary practices made
possible through the use of the technology are justifiably confronted with
heightened legal and ethical scrutiny. In fact, a thorough ethical analysis
has been proposed listing several prerequisites that, if satisfied, would pro-
mote a more "morally defensible" exclusionary policy. 4 First, there must
be scientific evidence linking a specific illness to a genetic variation. Second,
there are several conditional requirements: 1) the relative and absolute risks
for workers with the genetic anomaly should be large; 2) the incidents of
mislabeling individuals should be few and reversible; 3) the number of those
actually excluded should be very small; 4) there should be relatively few jobs
involved so as to avoid severe limitations on workers' employment choices;
5) the illness itself should be severe and irreversible; and 6) the tests should
not be disproportionately administered to groups which have traditionally
52. See supra note 12.
53. As previously mentioned, blacks have already been screened out of flying positions in
the Air Force. See supra note 16.
Women have also been subjected to exclusion. While not directly related to the methods of
genetic testing discussed in this Comment, some argue that because no tests are needed to
identify the trait of one's gender, exclusion on the basis of one's sex has been a relatively easy
and widespread practice. Some companies have excluded women because of suggestions that
their reproductive systems or the fetuses they could be carrying may be injured by certain
exposures, such as exposure to lead. As a result, many women have been excluded or removed
from jobs because of their childbearing capacity, regardless of their intentions not to have
children. Some women have gone as far as to submit to sterilization operations in order to stay
employed and support their families.
Such exclusionary policies ignore some very important facts. First, most female workers are
not pregnant at a given time. Only 8.8% of the female labor force is pregnant each year.
Second, male workers' reproductive systems are similarly affected by substances, and therefore
have the potential to cause fetal damage. Finally, protective equipment and safe exposure
levels should be provided for both sexes if the true concern is for fetal protection and not
simply to screen women out of traditionally male dominated jobs. Another option would be to
exclude workers of both sexes who are planning to have children. For a general discussion, see
Hearings, supra note 30, at 173-219 (statements of Joan E. Bertin, American Civil Liberties
Union, Velma Hunt, Pennsylvania State University, and Jeane Stellman, Columbia
University).




These standards are not designed to constrain exclusionary policies rely-
ing on genetic tests. On the contrary, they are a means by which employee
health protection can be promoted while, at the same time, discriminatory
exclusion can be prevented. However, those proposing these guidelines have
offered no explanation as to how they can be satisfied or how adherence can
be policed. Before an exclusionary policy could be "morally defensible",
these issues must be addressed.
Underlying Purposes
Diagnosis, research, information and exclusion constitute the more overt
purposes of genetic testing. However, there are also several underlying mo-
tives. First, employers may have a sincere concern for the health of their
employees, believing that protection through exclusion is the most effective
paternalistic policy available.5 6 Second, with increasing insurance costs, em-
ployers have a strong economic incentive to minimize their liabilities created
by occupational health hazards," and to avoid lawsuits arising from result-
ing injuries. 8 Third, genetic predictions could increase productivity by de-
creasing absenteeism due to illness.59 Finally, many employers contend that
it is not economically feasible to maintain a workplace safe for all employ-
ees, 60 as required under the Occupational Safety and Health Act.61 Genetic
tests could make this a more realistic objective, however, by screening out
those employees with the lowest tolerance levels, and thereby minimizing the
need for expensive safety equipment and procedures.
55. Id. Murray concludes that along with economic cost-effectiveness factors, moral and
political costs are very influential to evaluating exclusionary policies. Therefore, he suggests
that such programs be the "least restrictive alternatives" to other available means of improving
occupational health. Id.
56. See Hearings, supra note 30, at 151 (statement by Gilbert S. Omenn, M.D., Ph.D.);
Field, supra note 37, at 125; Otten supra note 11, at 1, col. 1. Another paternalistic purpose
was expressed by DuPont. Its medical director explained that screening blacks for sickle-cell
trait was purely for the "education and edification'of the individuals involved." Severs, Screen-
ing of Blacks by DuPont Sharpens Debate on Gene Tests, N.Y. Times, Feb. 4, 1980, at 13, col.
1.
57. Hearings, supra note 30, at 153. (statement by Gilbert S. Omenn, M.D., Ph.D.).
58. Murray, Warning: Screening Workers for Genetic Risk, 13 HASTINGS CENTER REP. 5,
6 (1983).
59. Id. See Otten, supra note 11, at 1, col. 1.
60. Severo, Genetic tests by Industry Raise Questions on Rights of Workers, N.Y. Times,
Feb. 3, 1980, at 36, col. 1.
61. 29 U.S.C. § 654 (a)(1) (1982).
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LEGAL IMPLICATIONS OF GENETIC SCREENING
While the technology of genetic screening presents a new method of pro-
moting occupational health, it implicates the rights and duties embodied in
the employer-employee relationship. However, the lack of legal precedent in
this area forces commentators to draw analogies and speculate as to how
emerging legal problems should be resolved. As the science continues to
gain momentum, examination of the legal and ethical issues should not be
permitted to lag behind the technological advances. While Congress has al-
ready taken an initial step through a series of hearings in the early 1980's,62
further evaluation and discussion is necessary before genetic testing becomes
an acceptable employment practice.
Recovery for Genetic Occupational Illness Under State Workers'
Compensation Laws
Workers' compensation laws were originally designed to provide a remedy
for occupational injuries. A distinction was made between occupational in-
juries and occupational diseases.63 However, with the increase of occupa-
tional disease in many industries came the abandonment of this dichotomy.
As a result, general compensation coverage for occupational diseases is pro-
vided by every state." Nonetheless, certain statutory requirements must be
met before a disease is considered work-related, and therefore compensable.
Some of these requirements can bar many workers' compensation claims for
occupational diseases, including genetic occupational diseases.
Generally, in order for an illness to be covered by workers' compensation
laws, an employee must prove that the disease suffered is truly occupational
in nature. The disease cannot be one that would have developed regardless
of any industrial exposure.65
If ... a disease is not a customary or natural result of the profes-
sion or industry, per se, but is the consequence of some extrinsic
condition or independent agency, the disease cannot be imputed to
the occupation or industry, and is in no accurate sense an occupa-
tion or industry disease.66
This requisite causal relationship between employment and illness is in-
cluded in most state definitions of occupational disease.67
62. See supra notes 11, 23 and 30.
63. LARSON, WORKERS' COMPENSATION LAW 231 (1984).
64. Id.
65. OTA Report, supra note 2, at 112-13.
66. BARTH, WORKERS' COMPENSATION AND WORK-RELATED ILLNESSES AND Dis-
EASES 94 (1982).
67. LARSON, supra note 63, at 233-34.
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While each state provides general compensation coverage for occupational
disease, the question of exactly how extensive this coverage is remains
open.68 The answer is unclear due to an underlying fear amongst some
states to allow overly broad coverage for occupational illness.69 Conse-
quently, these states have adopted restrictive statutory definitions of "occu-
pational illness".7" Therefore, whether an employee's disease falls within the
purview of a state's workers' compensation coverage clearly depends on sat-
isfying its definition for occupational illness. This is accomplished by estab-
lishing the necessary causal connection between the disease and the
employee's occupation. However, this threshold requirement can be difficult
to satisfy, particularly in the context of genetic occupational disease.
One obstacle to proving the causal link arises where the employee's disa-
bility is caused by an "ordinary disease of life", rather than a disease specifi-
cally related to the employee's job. In such a case, the workers'
compensation claim would be denied. 1 For example, a state statute could
make compensable a disability caused by the genetic occupational disease
thalassemic anemia.72 Thus, in a restrictive jurisdiction, anemia would con-
stitute an "ordinary disease of life" while thalassemic anemia would consti-
tute an occupational disease. Consequently, if an employee possessing the
thalassemic trait brought a claim for anemia caused by past lead exposure,
rather than specifically stating that the claim was for thalassemic anemia, he
would be denied recovery. This would be the result despite the fact that the
exposure was necessary to "activate" the trait giving rise to the anemia.73
The distinction is one of semantics and is based on a restrictive interpreta-
tion of the statute. Such an approach has a fatal effect on the outcome of a
workers' compensation claim.
A more formidable obstacle to establishing the causal relationship be-
tween disease and employment is the requirement that the disease be caused
solely by a chemical exposure without contribution from ANY other factor.
If the illness is attributable to any non-occupational cause, even if it is in
addition to an occupational cause, it may, in some jurisdictions, constitute
68. Id. at 233.
69. BARTH, supra note 66, at 93.
70. Id.
71. Id. at 95-96.
72. For a general discussion of this and other genetic and occupational diseases, see supra
note 3.
73. For a general discussion, see BARTH, supra note 66, at 96 (citing Asten Hill Mfg. Co.
v. Bambrick, 291 A.2d 354 (Pa. 1972) where the court denied a claim of disability due to lung
cancer that was caused by asbestos exposure; the claim, in order to be successful under the
workers' compensation statute, should have been brought for asbestosis).
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an "ordinary disease of life". 74 This poses a significant problem to employ-
ees whose claims are based on genetic occupational illnesses. The possession
of a genetic vulnerability to illness could be regarded as a factor completely
independent from the employee's occupation, even though the occupational
exposure is a necessary element to the illness becoming evident in the first
place. Thus, the employee's genetic makeup may, as an independent causa-
tive factor of the disease, bar compensation.73
There exists a general rule "that the employer takes the worker as he finds
him. '76 However, many states do not strictly adhere to this rule.77 Thus,
some courts have denied workers' compensation claims for disease where the
employee had a "preexisting condition" unrelated to the workplace. A dis-
ease arising from such a condition is not deemed, in some states, causally
related to employment.78 This approach creates a serious impediment to
claims brought by genetically susceptible employees because, clearly, genetic
conditions exist prior and unrelated to employment. Consequently, although
the occupational exposure must occur to trigger the onset of the disease, the
employee's genetic predisposition may bar recovery.79
The long latency periods of many genetic occupational diseases also frus-
trates an employee's ability to satisfy the causal relationship requirement.80
First, a long latency period can affect an employee's ability to remember
whether he ever was exposed during his employment to a particular sub-
stance that would have triggered the genetic occupational illness s.8  If an
employee cannot remember whether the exposure ever occurred at the work-
place, the causal link cannot be established.
Second, with the passage of time resulting from a long latency period
comes an increased burden of collecting the evidence necessary to demon-
strate the causal connection between occupation and disease. Records and
documents containing information of the occupational exposure are likely to
be unavailable after a long period of time has passed since that exposure first
74. Id.
75. For a general discussion of cases involving a determination of whether other causes
contributed to the illness, see id. at 96-98.
76. Id. at 115.
77. Id.
78. For a general discussion, see id. at 115-17.
79. A Survey of State Administrative Practices revealed that, of the states responding to
the survey, Missouri, Ohio and West Virginia would not compensate for preexisting conditions
unrelated to employment; Oklahoma and Tennessee were undecided on this issue; and Ala-
bama, Arkansas, Georgia, Louisiana, Maine, Maryland, Montana, Pennsylvania, South Da-
kota and Wyoming did not respond. Id. at 116.
80. Id. at 62-63. See OTA Report, supra note 2, at 113.
81. See BARTH, supra note 66, at 63.
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occurred. 2
Finally, the difficulties caused by long latency periods to proving workers'
compensation claims may actually be exacerbated by the eventual use of ge-
netic testing. If genetic becomes a highly predictive means of determining
the causes of some occupational illnesses, non-hypersusceptible claimants
will need to prove that, despite the absence of a genetic vulnerability, the
occupational exposure caused the illness. The relatively little understanding
of the etiology of occupational diseases makes this aa burdensome task. 3
Thus, a non-hypersusceptible claimant will have the impediments of the long
latency period of his illness compounded by the unavailability of a specific
test to prove that the cause of his condition was occupational. On the other
hand, the genetically susceptible claimant can rely on the genetic test results
to help establish that but for the occupational exposure, his genetic illness
would never have been triggered. Assuming he is not in a jurisdiction which
denies claims for preexisting conditions of multi-factor causes, he is likely to
recover workers' compensation.
Even if a claimant weeking workers' compensation for a genetic occupa-
tional disease can overcome these obstacles, the existence of a long latency
period and a restrictive statute of limitations can hamper his ability to bring
the suit in the first place. Most states include a statute of limitations in their
workers' compensation laws.8 4 There are three common types of statute of
limitations: 1) minimum exposure rule, 2) recent exposure rule, and 3) expo-
sure in the state rule.8 5 A brief examination of each rule reveals that they
can operate as significant bars to a worker's compensation claim for disease.
The minimum exposure rule requires an employee to prove that the haz-
ardous exposure occur within a specific minimum period of time in order for
a claim to be brought.8 6 For example, in the context of a claim for a genetic
82. See id. Generally, there are six factors pertinent to establishing the causal connection.
While these criteria have been relied upon in the context of disease resulting from radiation
exposure, they can also be applied to other types of exposure. They include:
1) The extent of the exposure and its relationship to the development of the disease;
2) Whether the disease is known to be related to the particular exposure;
3) The employee's predisposition or hypersensitivity to the effects of the exposure;
4) The effects of other agents to which the employee was exposed, either on or off the
job;
5) The existence of other sources of the particular exposure outside of the employee's
workplace, and
6) Exposure to the particular substance at a previous or subsequent job.
Id. at 65.
83. OTA Report, supra note 2 at 113.
84. BARTH, supra note 66, at 120.
85. Id. at 120-23.
86. Id. at 121.
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occupational illness, an employee would need to show that the exposure to
lead occurred within the specified time period prior to the contracting of
thalassemic anemia. If the disease arose before the beginning of this time
period, the employee's workers' compensation claim would be barred. 7
The minimum exposure rule may not as act as an obstacle to those em-
ployees whose claims involve diseases with long latency periods. In such
cases, the employees would be exposed to the hazardous substance within
the required minimum time period before actually contracting the disease.
However, some diseases may develop shortly after the occupational exposure
has occurred. Consequently, an employee may be barred from any recovery
simply because his particular disease had a relatively short latency period
and was quick to reveal itself.
The recent exposure rule also imposes difficulties for many workers'
claims. This rule bars claims for occupational diseases arising later than a
specified number of years from the time of exposure.88 For example, a state
law could require continuous occupational exposure to occur three years
prior to the onset of the disease in order for the recent exposure rule to be
satisfied. Therefore, if an employee develops a genetic occupational disease
after being exposed for only two years and eleven months, his workers' com-
pensation claim will be barred. This is also the result where the employee
has been exposed to a substance during the twenty years preceding the onset
of his occupational illness but such exposure was not continuous.89
Finally, the exposure in the state rule establishes a minimum time require-
ment in which the injurious exposure must occur in the particular state.90
This rule is designed to prevent employer liability for employees previously
exposed in other states.9' Consequently, an employee working for the same
employer for many years, but in plants located in different states, would be
prevented from bringing a workers' compensation claim.92 Furthermore, an
employee failing to satisfy the minimum time requirement, that is, by show-
ing that he was exposed to the hazardous substance within the specified time
period, shall also be unable to file his claim.
Despite these and other obstacles confronting employees bringing work-
ers' compensation claims for diseases, some claimants are nonetheless suc-
87. The minimum exposure periods vary between states. For example, Louisiana prohib-
its claims for diseases contracted during the first year of employment. Other states, such as
Georgia, Iowa, Kansas and Utah, have a five year minimum exposure level. BARTH, supra
note 66, at 121.
88. Id.
89. For other examples of the recent exposure rule, see id. at 121-23.




cessful. However, workers' compensation laws were not initially
promulgated with the intent to extend coverage to occupational diseases. In
addition, some states have had difficulty adopting laws to extend such cover-
age. As a result, there are many impediments inherent to some state work-
ers' compensation laws which create insurmountable burdens to claims for
illnesses. These hinderances combined with the lack of understanding sur-
rounding the etiology of genetic occupational diseases render workers' com-
pensation laws of little value to hypersusceptible employees. Thus, other
statutory frameworks must be explored in order to determine what may be a
source of protection and recovery for the genetically susceptible worker.
Employer Duties and Liabilities Under the Occupational
Safety and Health Act
The sole federal statute pertaining to an employer's duty to protect its
employees from occupational illness is the 1970 Occupational Safety and
Health Act ("OSH Act").9a It imposes a general duty on employers to
maintain a workplace free from "recognized" health hazards. 94 This respon-
sibility belongs only to the employer, and cannot be delegated to or assumed
by the employee.95 Many critics fear that genetic screening will delegate this
responsibility to the employee. By excluding the more vulnerable employ-
ees, employers would be relieved of their obligation to maintain and improve
environmental conditions in the workplace. 96 This is often referred to as
"blaming the victim".
Victim-blaming, however, ignores the possibility that workers not labeled
susceptible may subsequently contract the illness.97 By removing only bio-
logically predisposed individuals, an employer would be making the false
assumption that others are not at risk. Therefore, the sanctioning of high
exposure levels to less susceptible workers merely defers a substantial
amount of occupational illness and cost to a later date. As an alternative, an
employer may decide to use an overly inclusive genetic screening test in or-
der to avoid such consequences.9" This will help insulate the employer from
liability for occupational disease. However, it will also lead to the unjustified
93. 29 U.S.C. § 651-678 (1982).
94. 29 U.S.C. § 654(a). A "recognized" hazard is one which either the employer or the
particular industry regards as dangerous and there is a manner in which they are handled to
prevent the onset of disease. OTA Report, supra note 2, at 119.
95. OTA Report, supra note 2, at 119.
96. See Hearings supra note 11, at 51 (statement of Dr. Kennith B. Miller, Medical Direc-
tor, worker's Institute for Safety and Health); Diamond, supra note 29, at 244; Murray, supra
note 58, at 6; Samuels, supra note 3, at 574.
97. See Samuels, supra note 18, at 5; Severo, supra note 60, at 36, col. 2.
98. Employers have been criticized for using other types of screening devices based on
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exclusion of some less susceptible employees. Nonetheless, this approach will
be attractive to many employers because it may actually prove less expensive
to use an over-inclusive test than to more precisely determine each individ-
ual worker's susceptibilities.99
Of course, the threshold question is whether the Occupational Health and
Safety Administration ("OSHA") possesses the authority to regulate genetic
testing in the workplace. Although there have been conflicting opinions, it is
generally agreed that OSHA has such jurisdiction provided the applied regu-
lations relate to *promoting workplace health and safety. " This does not
mean, however, that the OSH Act is designed to protect workers' individual
rights. Its purpose is to protect their occupational health.' 1 Nor should the
conference of regulatory jurisdiction be confused with the notion that the
OSH Act requires an employer to conduct genetic testing. On the contrary,
it simply imposes a general duty to protect workers' health and safety, but it
does not specify the means by which that duty is to be carried out.10 2 There-
fore, it must be determined whether providing a safe workplace for even the
most susceptible employees is compatible with an employer's general duty to
protect workers' health and safety under the OSH Act.
The Secretary of Labor has promulgated strict limitations on the allowa-
ble exposure levels of various toxic substances.3 OSHA has the authority
to establish exposure levels so that "no employee will suffer material impair-
ment of health or functional capacity, even if exposed for his or her entire
working life."'" Yet, there is no mention as to whether such standards in-
clude consideration of hypersusceptible workers. It does, however, use the
invalid assumptions, and therefore resulting in overinclusive screening. See Comment, Occu-
pationally Induced Cancer Susceptibility: Regulating the Risk, 96 HARV. L. REV. 697, 703.
99. Id. at 703-04.
100. OTA Report, supra note 2, at 122. But see Hearings, supra note 11, at 127-28 (state-
ment of Mark A. Rothstein, West Virginia University School of Law) (suggesting that the
OSH Act would need to be amended because it deals with workplace conditions, not employee
rights).
101. See Whirlpool Corp. v. Marshall, 445 U.S. 1, 11-12 (1980).
102. OSHA confirmed that its standards do not mandate genetic testing of employees. It
stated that its regulations require only that a worker's general health status be identified and
that OSHA does not advocate exclusionary policies. It also acknowledged that genetic tests
could shift the responsibility of toxic control to employees. See United States Department of
Labor, OSHA Clarifies Reference to "Genetic Factors" in Medical Surveillance Requirements,
News, Feb. 20, 1980, at 1-2. The clarification came in response to questions over an OSHA
regulation stating that the required employee medical histories shall include "family and occu-
pational background, including genetic and environmental factors." See generally Severo, Fed-
eral Mandate for Gene Tests Disturbs U.S. Job Safety Official, N.Y. Times, Feb. 6, 1980, at 1,
36.
103. 29 U.S.C. § 655 (b)(5) (1982). See McConnell, Pre-Empolyment Genetic Testing in the
Chemical Industry, 1 COMPLEAT LAW 51 (1984).
104. 29 U.S.C. § 655 (b)(5) (1982) (emphasis added).
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term "no" employee, which could be interpreted as providing for the protec-
tion of all employees. Nonetheless, a more thorough examination of the stat-
ute reveals that it was not intended to provide for absolutely risk-free
workplaces.
While the language delegating authority to set safety standards appears
broad, the Secretary can impose standards only "to the extent feasible. ' 10 5
The judicial interpretation of this language actually restricts what could
otherwise be the Secretary's broad discretion in setting exposure levels. The
Supreme Court, in American Textile Manufacturers Institute v. Donovan
("the Cotton Dust case"),1"6 held that "to the extent feasible" requires that
a safety standard be technologically and economically feasible. In other
words, that it be capable of being met17 and feasible for the industry as a
whole, rather than for only an individual employer.10 8 The Court recognized
that the feasibility requirements were intended to relieve employers of the
duty to achieve "absolute safety" in the workplace."9 Consequently, when
confronted with protecting the health of genetically susceptible workers, the
members of an industry could argue that the proposed standard is beyond
the point of technological or economic feasibility, and therefore
unenforceable. 110
According to Section 3(8), the Secretary's standards must be "reasonably
necessary and appropriate to provide safe or healthful employment and
places of employment." 11' The Supreme Court has held that to satisfy this
requirement, the Secretary must determine that a workplace environment
poses a "significant risk" to employees, and that the risk could be eliminated,
or lessened, by altering employment practices. 1 2 The Court confirmed that
the congressional intent underlying the OSH Act was to eliminate significant
risks to employees, not to achieve absolute safety.'
Under this decision, the Secretary could only promulgate a standard
designed to protect hypersusceptible employees where he has demonstrated
that the industry's current exposure levels present a significant risk to the
105. 29 U.S.C. § 655 (b)(5) (1982).
106. 452 U.S. 490 (1981).
107. Id. at 508-09.
108. Id. at 514, 521 n.38.
109. Id. at 514.
110. See Schechter, Genetic Screening in the Workplace, 52 J. OCCUPATIONAL HEALTH &
SAFETY 8, 12 (1983).
111. 29 U.S.C. § 652(8) (1982).
112. Industrial Union Dept., AFL-CIO v. American Petroleum Institute, 448 U.S. 607,
642 (1978).
113. Id. at 646.
1988]
396 Journal of Contemporary Health Law and Policy [Vol. 4:375
health of those employees." 4 A "significant" risk may be shown in terms of
the odds in which an employee may become affected by an exposure level.
For example, if the odds are one in a billion that an individual will be af-
fected, the risk may not be considered significant. On the other hand, if the
odds are one in a thousand, the risk may warrant a change in the current
exposure level.' Thus, in order to guarantee safe exposure levels to geneti-
cally susceptible workers, the odds must reflect that a relatively significant
number of workers are at risk.
16
The Secretary is given the authority to prescribe medical examination pro-
cedures used in determining the effects of exposure levels.11 7 However, as
mentioned earlier, this does not necessarily include requiring genetic test-
ing. 1 8 Thus, because it does not mandate such tests, and because it provides
for neither employee rights, not an absolute risk-free workplace, the OSH
Act may prove to be of little help in protecting the health of genetically
susceptible employees.
Nonetheless, there are two possible protections that deserve mentioning.
First, the OSH Act provides for medical removal protection ("MRP"). 1 9
Currently, the OSHA standard for lead exposures requires that workers at
an increased risk to be removed to comparable jobs. 2 ° A similar medical
removal provision could be included in any standards governing genetically
susceptible workers where it is not otherwise technologically or economi-
cally feasible to lower exposure levels. 21
The second possible protection is Section 11 (c), which prohibits discrimi-
114. This would involve proving on the basis of substantial evidence, that at least more
likely than not, a significant risk exists. Id. at 653. However, the Court has left it to the
discretion of OSHA as to what constitutes a significant risk. This does not require scientific
certainty but, rather, only a reasonable prediction based on the "best available evidence." Id.
at 655-56.
115. See id. at 655.
116. An important question to a risk determination made when hypersusceptible workers
are involved is whether the calculation is made on the basis of the number of non-susceptible
or susceptible employees that could be affected. If it is on the basis of non-susceptible workers,
fewer will be predicted as being at risk because of a higher tolerance to occupational disease.
However, if susceptible workers are considered, their genetic vulnerabilities should increase
the number of those who would be affected, thereby requiring a lower exposure level and
affording this group of employees greater protection in the workplace. Thus, it is necessary
that the pool of workers examined in making a risk determination include those susceptible
employees in order to obtain an accurate estimate of the risk to the entire population of
employees.
117. 29 U.S.C. § 655(b)(7) (1982).
118. See supra note 87 and accompanying text.
119. Industrial Union Dept., 448 U.S. at 658.
120. 29 C.F.R. § 1910.1025(k)(I)(i) - (ii) (1986).
121. See Schechter, supra note 110, at 12.
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nation against an employee who exercises any right afforded by the OSH
Act.' 22 In Whirlpool Corp. v. Marshall,123 the Supreme Court applied this
protection to the right of an employee to refuse to perform a task because of
a reasonable apprehension that the working conditions present an imminent
threat of death or serious bodily injury, coupled with a reasonable belief that
there is neither the time nor opportunity to seek redress through established
procedures. '24
Therefore, a hypersusceptible employee may have the right to refuse to
work without fear of being unjustly discharged, where the work environment
poses an imminent risk to the employee due to his genetic condition, pro-
vided that no less drastic alternative is available. Proving such a threat is,
however, more difficult in these situations because of current disputes over
the validity of genetic testing.' 23 Moreover, because occupational illnesses
often entail extended latency periods, the hypersusceptible worker may not
meet the imminence requirement. 126
Similar to the common law, an employer's willful violation of his required
duties under the OSH Act can lead to civil and/or criminal penalties, de-
pending on the resulting injury to employees.' 27 One of these duties is to
provide a true and accurate representation of any report or record. Accord-
ingly, false statements concerning an employee's medical record justify im-
position of a penalty,' 28 and an employer who knowingly misrepresents an
employee's genetic test results is subject to penalties under the OSH Act.
Unlike common law, however, the Act prohibits an employer from relying
on whether an employee has consented to work under hazardous condi-
tions. 29 Hence, it is more difficult to shift the blame to the employee under
the OSH Act.
122. 29 U.S.C. § 660(c)(1) (1982).
123. 445 U.S. 1 (1980).
124. Id. at 10-11.
125. OTA Report, supra note 2, at 119.
126. Id.
127. See generally 29 U.S.C. § 666 (1986). One limitation on employee rights under the
Act is that no private right of action exists. Rather, a petition must be filed with the Secretary
of Labor in order to have the regulation enforced. OTA Report, supra note 2, at 119.
128. An employer who falsely misrepresents any application, record, report, plan or other
document is subject to a fine of not more than $10,000 or imprisonment of not more than six
months, or both. 29 U.S.C. § 666(g) (1982).
129. OTA Report, supra note 2, at 119.
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Employee Rights
Discrimination
Title VII of the 1964 Civil Rights Act
There is a significant concern that biological screening has the potential to
be used as a discriminatory device because genetic traits are often associated
with a person's racial or ethnic background.130 An employer generally has
the right to hire anyone it so chooses,1 ' and can establish the employment
criteria and conduct the testing necessary to determine which applicants sat-
isfy its standards. 132 Because employees must accept employers' policies, Ti-
tle VII provides that employees have the right to be free from employment
discrimination based on race, color, religion, sex or national origin. 133  Dis-
crimination generally takes two forms: (1) disparate treatment, which in-
volve a hiring policy that overtly discriminates against a protected group of
workers, and (2) disparate impact, which involves a hiring policy that may
be facially neutral, has a discriminatory effect.
134
In alleging disparate treatment, a plaintiff must show proof of the em-
ployer's discriminatory motive. 135 A prima facie case of discrimination in-
volves demonstrating that the plaintiff belongs to a group protected under
Title VII and has been denied employment despite his qualifications that
were the equivalent of those that the employer sought in its applicants.
136
Once a prima facie case has been established, the employer may assert a
"legitimate, nondiscriminatory reason for the employee's rejection."' 137 It is
at this point that the plaintiff may argue that the employer's facially neutral
130. See Hearings, supra note 11, at 103 (statement of Mark A. Rothstein, West Virginia
School of Law) (genetic screening often has a disparate impact along racial lines while cytoge-
netic methods do not). For example, population frequencies for the G-6-PD deficiency occur
in American Caucasians at .1%; American black males at 16%; British at .1%; Chinese at 2-
5%; European Jews at 1%; Filipinos at 12-13%; Mediterranean Jews at 11% and Scandinavi-
ans at 1-8%. OTA Report, supra note 2, at 124.
131. Hearings, supra note 11, at 103 (statement of Mark A. Rothstein, West Virginia Uni-
versity School of Law).
132. Rothschild and Werden, Title VII and the Use of Employment Tests: An Illustration of
the Limits of the Judicial Process, 11 JOURNAL OF LEGAL STUDIES 261, 262 (1982).
133. 42 U.S.C. §§ 2000e - 2(a) (1982).
134. OTA Report, supra note 2, at 123.
135. Id.
136. The four components of the prima facie case of racial discrimination include: 1) that
the individual belongs to a racial minority; 2) that he applied and was qualified for a job for
which the employer was seeking applicants; 3) that, despite his qualifications, he was rejected;
and 4) that, after his rejection, the position remained open and the employer continued to seek
applicants from persons of complaintant's qualifications. McDonnell Douglas Corp. v. Green,
411 U.S. 792, 802 (1973).
137. Id.
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hiring policy serves merely as a "pretext" for discriminatory actions. 38
In the context of genetic screening, disparate treatment could occur here
only those workers of a particular racial or ethnic background associated
with a genetic trait are subjected to the tests, or excluded altogether. 139 Fur-
thermore, it could occur even where all applicants are subjected to the ge-
netic tests, but an applicant belonging to a protected group tests positive for
the genetic trait and is refused employment, regardless of his qualifications.
While the employer can defend its decision on the basis of the test results,
the applicant can assert a pretext argument if he can show that the employer
hired another applicant who tested positive but was not of the same racial or
ethnic background, or sex.140
An employer can defend charges of discriminatory treatment by demon-
strating a "bona fide occupational qualification" ("BFOQ")."4' The BFOQ
requires that employment criteria based on religion, sex or national origin be
"reasonably necessary to the normal operation of [the] particular business or
enterprise."' 42 However, no BFOQ can be based on an employee's race.
Some commentators have criticized the provision for permitting employ-
ment practices designed to minimize costs, even if they create a discrimina-
tory result. 143 Therefore, employers using genetic screening methods would
merely need to show that, despite a discriminatory effect, the tests are neces-
sary to minimize insurance and other costs related to occupational illness
from chemical exposures.
Disparate impact involves employment practices implemented without
any discriminatory intent, but having an adverse effect on a group protected
under Title VII that cannot be justified by business exigencies or by job re-
quirements. 1" Unlike disparate treatment, proof of discriminatory intent is
not required.' 45
The leading Supreme Court case which confronted the issue of disparate
138. Id. at 804.
139. See Note, Employment Discrimination Implications of Genetic Screening in the Work-
place under Title VII and the Rehabilitation Act, 110 AM. J. LAW & MEDICINE 323, 329
(1984). [herinafter Employment Discrimination].
For example, DuPont previously tested only its black employees for sickle cell anemia. See
Severo, Screening of Blacks by DuPont Sharpens Debate on Gene Tests, N.Y. Times, at 1, 13
(Feb. 4, 1980). Similarly, the previous policy of the United States Air Force whereby it re-
jected only black candidates is an example of such discrimination. See supra note 16.
140. See Employment Discrimination, supra note 139, at 330.
141. 42 U.S.C. § 2000e - 2(a)(2) (1982).
142. Id.
143. See, e.g., Rothschild and Werden, supra note 132, at 265.
144. OTA Report, supra note 2, at 123.
145. Id.
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impact is Griggs v. Duke Power Co.,146 in which the Court recognized that
the purpose of Title VII was not only to proscribe overt discriminatory em-
ployment practices, but also those that are "fair in form, but discriminatory
in operation." 117 Thus, an employer's good intentions or absence of discrim-
inatory intent becomes irrelevant where its employment practices discrimi-
nate. However, if an employer can prove that the job criteria has a
"manifest relationship to the employment in question,"' 48 i.e., is necessary
and relates to job performance, its use will not be prohibited.149
The disparate impact analysis was refined into a three-step approach in
Albermarle Paper Co. v. Moody. 5' First, a plaintiff must establish a prima
facie case of discrimination.' 5 ' Second, once such discrimination is shown,
the burden shifts to the employer to prove that the tests are related to job
performance. Finally, if the employer meets this burden, the plaintiff may
offer evidence that there are alternative tests or practices that could mini-
mize the disparate impact while serving the employer's business interests.'52
Genetic screening practices have the potential to create a disparate impact
due to the tendency of genetic traits to vary along racial or ethnic lines.
Thus, an applicant could establish a prima facie case of discrimination by
showing that the tests screen from jobs the workers of a particular racial or
ethnic group frequently possessing a genetic trait disproportionately. The
employer's "business necessity - job related" defense in this context would
entail proof that: (1) there is a valid reason for excluding workers who are
presently capable of performing the required work but who may become
physically unable to do so in the future, i.e., for productivity reasons or to
decrease disability insurance costs, (2) it is important to the business that
employees not be suffering from an occupational illness, (3) the specific
screening procedure used is accurate and reliable in identifying the presence
of the genetic trait, (4) there is a high correlation between the trait and the
individual's susceptibility to disease at the legal exposure levels, (5) the com-
pany cannot feasibly decrease exposure through engineering controls, pro-
tective devices, or job placement, and (6) the company cannot insure itself at
a reasonable cost against potential tort liability.'
53
146. 401 U.S. 424 (1971).
147. Id. at 431.
148. Id. at 432.
149. Id. at 431.
150. 422 U.S. 405 (1975).
151. See supra note 136.
152. Albermarle Paper Co., 422 U.S. at 425.
153. OTA Report, supra note 2, at 125. Once the employer has proposed its defense, the
court must determine whether the need for the practice sufficiently outweighs the disparate
impact. Id.
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Validation of a genetic test is an essential element to this defense. An
employer using tests which it asserts are related to job performance, must
show that the tests have undergone professional validation studies pursuant
to the Uniform Guidelines on Employee Selection Procedures
("UGESP") 154 issued by the Equal Employment Opportunity Commission
("EEOC"). Under the UGESP, an employer must demonstrate, through
available data, that the test is "predictive of or significantly correlated with
important elements of work behavior that comprise or are relevant to the job
or jobs for which candidates are being evaluated."' 155
Currently, genetic screening methods are incapable of satisfying these
standards due to uncertainty about its predictive value. 15 6 Thus, use of such
tests would be violative of Title VII. In cases in which similar concerns
arose, courts generally ordered the employer to develop new testing proce-
dures that would be acceptable under the UGESP.157 If the predictions that
genetic screening will become a more accurate technology prove true'5 8,
however, the tests may eventually meet the UGESP requirements and be
considered appropriate for use despite any disparate impact on groups of
employees.
Although it is unsettled as to whether Title VII will provide the necessary
protection for victims of genetic discrimination, it has been regarded as
likely means of redress.' 59 A bill has been introduced in Congress to amend
Title VII to specifically cover discrimination on the basis of an employee's
genetic characteristics. '6
The Rehabilitation Act
The 1973 Rehabilitation Act ("the Act") 16' has also been suggested as a
means to prevent employment discrimination against genetically susceptible
154. 29 C.F.R. § 1607 (1986).
155. Id. at § 1607.4(c).
156. See supra note 32-38, and accompanying text.
157. See Smith, The EEOC's Standards for Employment Testing, 8 N.Y.L.J., Sept. 16,
1985, at 22, col. 3.
158. See infra note 234.
159. See Hearings, supra note 11, at 117 (statement of James English, Esq. United Steel-
workers of America), See id. at 127 (statement of Mark A. Rothstein, West Virginia University
School of Law) (suggesting that Title VII would be the "best place to start with respect to
employment discrimination").
160. The bill exempts from the definition of "genetic characteristics" genetically linked
conditions creating undue hardship on an employer's business. Thus, an employer could still
discriminate on the basis of a genetic trait where the costs of protecting a susceptible employee
would be prohibitively expensive. See OTA Workshop, supra note 45, at 40.
161. 29 U.S.C. §§ 701-796 (1982).
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workers, particularly through Sections 503 and 504. Section 503162 provides
that any federal contract in excess of $2,500 must include a provision requir-
ing the employer "to take affirmative action to employ and ad-
vance... qualified handicapped individuals."'1 63 Section 504 "6 prohibits a
federally funded program from discriminating against a handicapped person
solely on the basis of his handicap.
1 65
The Act refers to discrimination based on an individual's handicap.
Therefore, in order for the Act to protect persons with genetic susceptibili-
ties, such persons must satisfy the Act's definition of "handicapped." Ac-
cording to the Act, a handicapped person is one who: (1) has a physical or
mental impairment that substantially limits one or more of the person's ma-
jor life activities, (2) has a record of such impairment, or (3) is regarded as
having such an impairment.' 66 Furthermore, a person must be "otherwise
qualified" for employment in order to fall within the Act's coverage.'
67
The definition's first requirement is that a genetic trait constitute an im-
pairment and constitute a substantial limitation of a person's major life ac-
tivities. Genetic testing, however, generally identifies persons who have the
potential of acquiring a physical impairment due to chemical exposures.,
61
Regulations of the Department of Health and Human Services ("HHS")
governing Section 504, defines a physical impairment, by reference to a per-
son's current condition.'69 Unless the potential condition is considered an
impairment under this definition, or unless the regulations are amended to
include such conditions, a genetically susceptible individual appears to be
unprotected under Section 504.
There is no definition of impairment with the Office of Federal Contract
Compliance Program ("OFCCP") regulations governing Section 503. How-
ever, the federal district court for the District of Hawaii in E.E. Black, Ltd.
162. Id. at § 793.
163. Id. at § 793(a).
164. Id. at § 794.
165. There are, however, limitations inherent to the available protection under Sections
503 and 504. For instance, employers covered by the Act include either government contrac-
tors or federal funds recipients. Although this covers approximately 3 million firms, or about
one-half of American businesses, OTA Report, supra note 2, at 126, the Act will not address
the actions of employers not within its scope. Thus, many handicapped persons remain
unprotected.
166. 41 C.F.R. § 60-741.2 (1986).
167. 29 U.S.C. § 794 (1982).
168. See OTA Report, supra note 2, at 127.
169. A physical impairment is defined as "any physical disorder or condition, cosmetic
configurement, or anatomical loss affecting one or more of the following body systems: neuro-
logical; musculoskeletal; special sense organs; cardiovascular; reproductive; digestive; genito-
urinary; hemic and lymphatic; skin; and endocrine." 45 C.F.R. § 84.3(j)(2)(i)(A) (1986)..
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v. Marshall,17° interpreted impairment as "any condition which weakens,
diminishes, restricts or otherwise damages an individual's health or physical
or mental activity."' 71 Under this broad definition, 7 ' a hypersusceptible
worker could be protected by Section 503.173 Notwithstanding the court's
interpretation of Section 503, a uniform definition of impairment that would
afford hypersusceptible workers protection under both Sections 503 and 504
is needed.
The next question is whether a person's job constitutes the type of activity
which the Act intended to address. Recently, the Supreme Court declared
that "working" is a major life activity within the meaning of the Act. 174
Similarly, the OFCCP regulations regard employment and vocational train-
ing as activities which can be limited by impairments. 17  Thus, under both
Sections 503 and 504, if a person's ability to work is limited by a genetic
susceptibility, it is the type of activity which the Act addresses.
The presence of an impairment will not, however, automatically afford an
individual the Act's protection. Rather, the focus "must be on the individ-
ual job seeker, and not solely on the impairment or the perceived impair-
ment."'176 Therefore, a case-by-case determination is made of whether a
person's handicap substantially limits his employability.' 77 The "substan-
tially limits" language refers to the degree to which an impairment affects
employability. 7  The OFCCP regulations state that a "handicapped indi-
vidual who is likely to experience difficulty in securing, retaining or advanc-
ing in employment would be substantially limited."' 179
In E.E. Black, the district court established a set of factors for determin-
ing what constitutes a substantial limitation including: (1) the number and
type of jobs from which the impaired individual is disqualified, (2) the rele-
vant geographical area, and available employment in areas to which the ap-
plicant has reasonable access, and (3) the applicant's own expectations and
170. 497 F.Supp 1088 (D.Haw. 1985).
171. Id. at 1098.
172. The court recognized that Congress intended the Act "to have broad coverage and
effect." Id. at 1097-98.
173. The effects of some genetic susceptibilities can lead to anemia, headaches, shortness of
breath and lethargy. See generally supra note 3. Clearly, such conditions would tend to
weaken, diminish, restrict or otherwise damage a person's physical activity.
174. School Board of Nassau County v. Arline, 107 S.Ct. 1123, 1129 n.10 (1987). Cf 45
C.F.R. § 84.3(j)(2)(ii) (1986).
175. 41 C.F.R. § 60-741.30, App. A. (1986).
176. E.E. Black, 497 F.Supp. at 1100.
177. Id.
178. 41 C.F.R. § 60-741.30, App. A. (1986).
179. Id.
1988]
404 Journal of Contemporary Health Law and Policy [Vol. 4:375
training.' 80 Under these standards, a genetically susceptible worker could
be deemed substantially limited from employment if his impairment, or per-
ceived impairment, precludes him from jobs that are the "same or similar"
to those offered by employers in the area to which the employee has reason-
able access. 8 1
Yet another obstacle confronting hypersusceptible workers in securing the
Act's coverage is their inability to show a record of impairment under part
two of the definition. To have a record of impairment an individual must
have a history of, or have been misclassified as having, an impairment.18 2
Because genetic conditions often involve extended latency periods, it would
be difficult to establish a record demonstrating its history and effects.' 8
3
However, the "having a record" requirement could be satisfied if the genetic
test results were considered sufficient to establish a record of the employee's
potential impairment. Alternatively, a hypersusceptible employee could be
misclassified as having an impairment that substantially limits his ability to
work, when his condition has not caused such an effect. Such would be the
case where the mere possession of a genetic vulnerability by an employee has
led to his being considered to have an impairment despite the lack of any
resulting limitation on his ability to work. Thus, this misclassification would
satisfy the definition of having a record of impairment thereby bringing the
employee within the purview of the Act.
The third part of the definition of handicapped persons does not require
that an individual have an actual impairment to be protected by the Rehabil-
itation Act. Rather, he need only be perceived as having an impairment 4
that substantially limits his ability to work due to the negative reaction of
others.' "8 5 This part of the definition could actually provide to be the most
persuasive support for the extension of the Act's coverage to genetically sus-
ceptible individuals.
Because a genetic condition is not a visible physical condition and is dis-
coverable only through genetic testing, employment disqualification could
result from an employer's perception that the vulnerability will impair the
employee's ability to work. Furthermore, discrimination based on an em-
ployee's belonging to a particular racial or ethnic group known by the em-
ployer to have a high frequency. of genetic vulnerability, despite that
180. E.E. Black, 497 F.Supp. at 1100-01.
181. See id. at 1101.
182. 45 C.F.R. § 84.30)(2)(iii) (1986).
183. In Arline, the record was established by the hospitalization of the employee due to her
impairment. 107 S.Ct. at 1128.
184. See Southeastern Community College v. Davis, 442 U.S. 397, 405-06 n.6 (1979).
185. Arline, 107 S.Ct. at 1129.
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individual employee's genetic makeup, could also occur. Discrimination on
the basis of such perceptions, regardless of whether the impairment actually
exists, is prohibited by the Act. 186 Therefore, an individual, currently
healthy, who tests positive for a genetic susceptibility, such a person who is
simply a member of a racial or ethnic group, could not be excluded from a
job on the basis of the employer's perception that he could eventually de-
velop an occupational disease.
This has three important effects. First, it insures that susceptible employ-
ees who possess a genetic trait, but never contract the occupational disease
associated with that trait, are not unjustly excluded from a job. Second, it
protects non-susceptible employees who test positive due to over-inclusive
tests from being unjustifiably disqualified from employment. Third, it helps
to minimize exclusion based on a person's racial or ethnic background.
Finally, there is the question of the effect of the Act's "otherwise quali-
fied" requirement.18 7 An otherwise qualified person is one who is able to
meet all of the program's requirements despite his handicap:188 That is, one
who can perform "the essential functions of the job" with reasonable accom-
modation.189 Therefore, reducing exposure levels' 90 or providing safety
equipment could constitute a reasonable accommodation to otherwise quali-
fied hypersusceptible workers, provided these steps do not create an undue
financial or administrative burden on the employer. 91
Once a handicapped person covered by the Act has been disqualified from
employment, the employer may be required to justify this decision. An em-
ployer covered by Section 503 must show that the job criteria he used for
screening purposes is consistent with business necessity and the safe per-
formance of the job.' 92 Therefore, to defend genetic screening under Section
503, employers need to prove that a job involves exposure to a substance
likely to cause illness in individuals possessing a certain genetic trait. Fur-
186. See 41 C.F.R. § 60-741.30, App. A, (1986); 45 C.F.R. § 84.3(j)(ii) (1986) (both defin-
ing the term "regarded as having an impairment").
187. "[O]nly those persons who are both handicapped and otherwise qualified are eligible
for relief." Arline, 107 S.Ct. at 1129-30.
188. Davis, 442 U.S. at 406.
189. 41 C.F.R. § 60-741.2 (1986); 45 C.F.R. § 84.3(k) (1986). An employer may make a
reasonable accomodation by 1) making facilities used by employees readily feasible to and
usable by handicapped persons, and 2) job restructuring, part-time or modified work sched-
ules, acquisition or modification of equipment or devices, the provision of readers or interpret-
ers, and other similar actions. 45 C.F.R. § 84.12(b) (1986).
190. However, the OTA Report states that it is unlikely that an employer would be re-
quired to lower exposure levels below current OSHA standards in order to accomodate hyper-
susceptible employees. OTA Report, supra note 2, at 130.
191. Davis, 442 U.S. at 412.
192. 41 C.F.R. § 60-741.6(c) (1986).
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thermore, they must be able to support the predictive value of the screening
techniques. 193
A comparable defense exists under Section 504, however, Section 504 only
requires that the employment criteria be "job-related."' 194 Furthermore,
there cannot be available alternative job-related tests that do not screen out
as many handicapped persons as does the employer's test.' 95 Therefore,
under Section 504 employers using genetic screening tests must demonstrate
that these tests are related to the job in question 9 6 and that they do not
screen out genetically susceptible employees more frequently than other
available tests. The first prong of this defense could be satisfied where the
test relates to a job involving a chemical known to trigger an exposed em-
ployee's susceptibility. The second prong places the burden on the Director
of the Office of Civil Rights of the HHS to examine what alternative tests
and criteria are available. 197
The Act imposes an affirmative duty on employers to make a reasonable
accommodation for otherwise qualified handicapped employees.' 98 How-
ever, if the accommodation creates undue financial and administrative bur-
dens, the employer's failure to promote the handicapped person is not
considered discrimination within the meaning of Section 504.'9' The de-
fense of undue hardship is available under both Sections 503 and 504.200
Additionally, discrimination will not be found where the reasonable accom-
modations do not overcome the effects of a person's handicap.2° ' What is
required to remedy discrimination is simply that the reasonable accommoda-
tions be made, not that they be successful.
Under Section 503, factors influencing the undue hardship defense are the
business necessity of an employer's employment policies and the financial
193. The regulations promulgated under Section 503 provide two standards which must be
met in defending one's employment selection methods. The methods must 1) relate to the
job(s) for which a handicapped individual is applying; and 2) be consistent with business neces-
sity and job safety. 41 C.F.R. § 60-741.5(c)(2) (1986).
194. 45 C.F.R. § 84.13(a) (1986).
195. Id.
196. As previously noted, Title VII requires that the criteria "manifest a relationship to the
job and job performance." See supra notes 133-134 and accompanying text. However, the
courts may not necessarily follow the same standard in Rehabilitation Act cases. Thus, the
outcome of a Section 504 case depends on how the job-related requirement is defined. See
OTA Report, supra note 2, at 129.
197. 45 C.F.R. § 84.13(a) (1987).
198. See Arline, 107 S.Ct. at 1131 n.19. This obligation is not limited to modifying current
working conditions. Employers can accomodate handicapped employees by transferring them
to alternative job positions. Id.
199. Id.
200. See 41 C.F.R. § 60-741.6(d) (1986); 45 C.F.R. § 84.12(a) (1986).
201. See Arline, 107 S.Ct. at 1128 n.7.
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burden created by the suggested accommodation.2"2 Similarly, under Sec-
tion 504, no accommodation need be made if the employer demonstrates
that the federal program's size, budget, structure of the workforce, or the
nature and cost of the accommodation would create an undue hard-
ship.2°3Consequently, because of the expenses often associated with provid-
ing safer workplace, it is likely that the "undue hardship" defense will be
readily available to many employers. Nonetheless, there are less costly alter-
natives available that could help protect susceptible employees. For exam-
ple, an employer could implement shift rotations, divide maximum exposure
time, increase monitoring and medical surveillance, and provide personal
protection equipment. 2°
State Law
Lack of assurance and agreement concerning the federal statutory protec-
tion against genetic employment discrimination has prompted some states to
enact their own legislation. For example, New Jersey specifically prohibits
discrimination on the basis of an individual's atypical cellular or blood
trait.205 Both Florida206 and North Carolina2 7 have eliminated the sickle-
cell trait as an employment criteria. Some anticipate that state laws, rather
than federal legislation, will play a major role in regulating the use of genetic
screening methods in the workplace.20"
Privacy Rights and Confidentiality
Because of the intrusive nature of genetic tests, privacy rights are in dan-
ger of infringement. 209 The tests have the potential not only to disclose a
person's genetic makeup, but also his medical history, drug use, diet, the
presence of sexually transmitted diseases, and a predisposition to illnesses
other than those related to his occupation (ie. schizophrenia, Alzheimer's
disease, heart disease, cancer).210 Where there is a lack of privacy, and these
202. 41 C.F.R. § 60-741.6(d) (1986).
203. 45 C.F.R. § 84.12(c)(1)-(3) (1987).
204. See OTA Report, supra note 2, at 130.
205. N.J. Stat. Ann. § 10:5-12 (West 1986).
206. Fla. Stat. Ann. § 488.075 (West 1986).
207. N.C. Gen. Stat. § 95-28.1 (1985).
208. See Palisano, supra note 1, at 70.
209. See President's Commision, supra note 6, at 42-43. An American Civil Liberties
Union ("ACLU") committee is investigating the privacy issues of genetic testing in the work-
place and will issue a report of its conclusions and recommendations. Palisano supra note 1, at
69.
210. See Kingsley, Listen to Your Genes, NEw REPUBLIC, Aug. 11, 1986 at 4. See also,
Palisano, supra note 1, at 69.
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overreaching test results do not remain confidential between the employee
and the physician, it appears that the benefits are no longer intended for the
worker's health, but for the employer's best interests.
An employee's rights to privacy and confidentiality can be implicated as a
result of the relationships existing between the employer, the company phy-
sician and the employee. Traditionally, no physician-patient relationship ex-
ists between the company physician and job applicants. 2 11  However, the
doctor does act as an agent to the employer. Consequently, an applicant's
interest in the confidentiality of test results is often regarded as secondary to
company interests.21 2 Furthermore, where current employees are tested, the
results can easily be made available to employers.2 1 a
Along with questions concerning an employer's access to medical test re-
sults, debate continues over the availability of test data to other third parties,
such as insurance companies, potential employers, unions and family mem-
bers. 214 The possibility that applicants could be "blackballed" for revealing
their genetic makeups to other employers has raised significant concern that
privacy rights may be infringed, and that many applicants will be classified
as undesirable workers for future employment.21 5 Unions also have an inter-
est in obtaining information in order to aid them in their negotiations with
employers over workplace conditions and safety.
21 6
A Presidential Commission Report recommends that genetic testing infor-
mation should be given to third parties only where the person screened has
provided explicit consent.21 7 However, the Commission Report suggests that
confidentiality is only a qualified right and, under some circumstances, it
may be overridden.21 8 Moreover, a waiver of confidentiality may be implied
211. Samuels, supra note 18, at 9-10. The OTA Report states that this view may be chang-
ing. A physician-patient relationship may stem from several factors, including the nature of
the examination, the expectations of both physician and the applicant, the existence of a con-
tinuous medical relationship and whether the applicant consented to the examination. OTA
Report, supra note 2, at 115.
212. Samuels, supra note 3, at 576. See also OTA Report, supra note 2, at 115.
213. Samuels, supra note 3, at 576. See also, OTA Report, supra note 2, at 117-18.
214. See OTA Workshop, supra note 45, at 40. Generally there are no industrial policies
pertaining to either confidentiality of employee records or the use of employees' private doc-
tors for medical surveillance purposes. Hearings, supra note 30, at 35 (statement of Howard D.
Samuels).
215. See Appleson, Genes and Jobs, 68 ABA J. 1061, 1063 (1982). See also Severo, supra
note 60, at 36, col. 1.
216. Diamond, supra note 29, at 246.
217. President's Commission, supra note 6, at 42.
218. These circumstances include: (1) where reasonable efforts to elicit voluntary consent
to disclose have been unsuccessful; (2) where there is a high possibility that harm will occur if
information is not disclosed and, once revealed, the test results will prevent the harm from
occuring; (3) where the harm would be serious if not averted; (4) where approriate precautions
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where an employee has consented to an employment examination, and has
knowledge that the test is for his own benefit and that no duty of confidenti-
ality is owed to him by the company physicians." 9
The likelihood of unauthorized disclosure of employee medical informa-
tion has generated some action. For example, OSHA provides that all legal
and ethical obligations pertaining to the confidentiality of employee medical
records must be upheld. 2 1 It also requires employers not to reveal an em-
ployee's identity where his medical records are requested by a third party."'
Additionally, state governments have become involved in determining the
scope of disclosure. California, for example, enacted legislation mandating
employers to devise procedural protections to ensure confidentiality and pre-
clude unauthorized disclosure of employee medical information."' Califor-
nia also requires the employee's written consent to authorize release medical
information." 3
Inevitably, without guarantees of privacy and confidentiality, employees
will be unwilling to participate in employment testing programs established
only for research purposes. Where tests are used as conditions of employ-
ment, the most effective protections should be proffered so as to prevent in-
fringement of workers' rights. This is not to suggest that third parties'
interests in having access to the information be disregarded entirely. The
objective is to reach a balance between the competing rights and interests in
each case by weighing the severity of the risks and burdens caused by not
disclosing the information against the degree by which employees' rights will
be infringed.'24
Employee Access to Medical Records: The Right to Know
Information given to employers or third parties is not the only concern
over the accessibility of genetic testing results. Employees themselves cer-
are taken to ensure that only the genetic information needed for diagnosis and/or treatment is
disclosed. Id. at 44.
219. OTA Report, supra note 2, at 118.
220. 29 C.F.R. § 1910.20(a) (1986).
221. 29 C.F.R. § 1910.20(e)(2)(iii)(B) (removal of employee's personal identifier where a
third party requests access to medical records and denial of that request where such removal is
not feasible).
222. Cal. Civ. Code § 56.20(a) (Deering Supp. 1987).
223. Id. at § 56.20(c).
224. These risks and burdens include those experienced by insurance companies, family
members in danger of contracting a communicable disease, and taxpayers who ultimately pay
the price for occupational health. Thomas Murray, a specialist in medical ethics, suggests that
company medical officers need only provide a general opinion of an employee's health and
work capabilities when disclosing information to third parties. Otten, supra note 11, at 8, col.
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tainly have a legitimate interest in obtaining tests results. An important
function of genetic testing is to inform people of their biological makeup and
to allow them to make informed choices about their futures and well be-
ing."' OSHA, for example, guarantees workers access to their medical
records to promote this objective.226
Notwithstanding federal statutory rights, several states also provide for
employee access to employment medical records.22 7 The common law also
imposes a duty on employers to warn their employees of dangers in the
workplace. 228 Arguably, this includes a duty to make medical records that
contain such warnings available to employees. However, because applicants
are not considered employees, the "right to know" guarantees may not be
applicable to them. Thus, many job applicants remain at risk of being ex-
cluded from employment on the basis of their medical records without ever
knowing the reasons for that decision.
Autonomy
Closely linked to the issues of employee access to medical records is the
employee's right to decide how or if to proceed once he receives the informa-
tion. Based on an individual's informed judgment, should he be given the
right to self-determination regarding his employment, regardless of whether
this decision is in his best interest? Some commentators support the argu-
ment that where the individual demonstrates sufficient competency, his deci-
sions should be respected and not interfered with by others.229 However,
autonomy may be limited by such factors as the particular job requirements,
available resources or information, and accepted rules of behavior. 230 Au-
tonomy may, however, be compromised if an employee is not made fully
aware of the possible consequences of a worker's health condition or is un-
225. President's Commission, supra note 6, at 59.
226. See generally 29 C.F.R. § 1910.20(e)(1986). However, company physicians still retain
a certain degree of discretion over disclosure to employees where the tests indicate that an
individual is suffering from a terminal illness or psychiatric condition. 29 C.F.R.
§ 1910.20(e)(2)(ii)(D)(1986).
A further restriction on employee access arises where a disclosure results in revealing a
company "trade secret". 29 C.F.R. § 1910.20(f) (1986). In such circumstances, the employer
is required to provide alternative information to aid employees in identifying the cause of their
illness. Id.
227. See e.g., Conn. Gen. Stat. Ann. § 31: 128(c) (West Supp. 1986); Me. Rev. Stat. Ann.
tit. 26, § 631 (1986); Ohio Rev. Code Ann. § 4113.23 (1986); Wis. Stat. Ann. § 103.13 (West
Supp. 1986).
228. Diamond, supra note 29, at 248.
229. See generally OTA Report, supra note 2, at 142.
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able to understand its severity.2 31 In the case of preemployment genetic
screening, an applicant's autonomy could be constrained by exclusion from
an occupation without any regard for his judgment or willingness to take
any attendant risks.
Because the right to self-determination enjoys significant importance in
American society, it has been recommended that participation in screening
programs be voluntary. 232 In the employment context, genetic screening or
monitoring tests could not be used as conditions to employment, and an
employee's refusal to be subjected to the tests could not preclude or remove
him from a particular job. Currently, however, "unless the test procedure
violates a specific statute, regulation or collective bargaining agreement,
there is no constitutional or common law right to refuse.",
233
THE FUTURE OF GENETIC SCREENING IN THE WORKPLACE
Progress in the field of genetic testing is increasing in geometric propor-
tions. Many commentators predict that genetic screening of employees will
soon become a common industrial practice.234 There are others who con-
tend that because there are tests already capable of identifying the link be-
tween the occupational environment and specific disease, such tests should
be employed without delay.235 Despite any debate over the exact time in
which this astonishing technology will actually be put to further and more
common use, there is significant agreement that it will inevitably become a
reality and that there is an urgency to settle the attendant legal, ethical and
social issues before that time arrives.
One step in this direction was the approval by Congress to establish a
Biotechnology Ethics Board.236 In addition, much time and effort has been
contributed to plans for resolving the many controversial issues surrounding
231. Id
232. See e.g., President's Commission, supra note 6, at 47.
233. OTA Report, supra note 2, at 116.
234. See e.g., President's Commission, supra note 6, at 11 (predicting that, before the end
of the century, genetic screening and counseling will have significant influence in both public
health and individual medical care); Hearings, supra note 20, at 29 (statement of Congressman
Gore) (estimating that genetic tests will become significantly accurate and predictive within 2
to 10 years); Palisano, supra note 1, at 67 (suggesting that within 15 years genetic screening
tests will be an integral part of preemployment examinations); Englade, supra note 13, at 21
(quoting a prediction that genetic screening will be "in full force" by the end of the century
and will "call forth a major national debate on social policy").
235. Otten, supra note 11, at 8, col. 3 (quoting Gilbert Omenn). But compare Hearings,
supra note 11, at 52 (statement of Kenneth B. Miller, Medical Director, Workers' Institute for
Safety and Health) (stating that genetic screening will rarely, if ever, have a significant impact
on occupational health).
236. Palisano, supra note 1, at 68.
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genetic testing while, at the same time, promoting its research and eventual
use. One interesting model is a type of "three-way arrangement" between
unions, management and universities that plan to conduct research, identify
the occupational health problems and make recommendations collectively.
Such cooperative activity has been used in the past and could serve to pro-
tect the relevant competing interests.2 37 Labor organizations have also sug-
gested the enactment of "risk management" legislation that would prescribe
the conditions under which medical surveillance could take place. These
proposals include: (1) protecting confidential counseling, (2) maintaining en-
vironmental controls in the workplace, (3) promoting employee participa-
tion in medical surveillance and treatment programs, (4) providing
community based programs to help past and currently exposed workers and
their families, and (5) promoting educational and research programs to im-
prove the accuracy of tests and their interpretation.238 There are also re-
quests for government regulation, of public and private employers that
implement genetic testing, in order to ensure the protection of hypersus-
ceptible workers' rights and a safe workplace for all employees. 239 Finally,
biotechnology companies are increasing their efforts to develop predictive
tests. In fact, it is believed that the market for genetic screening tests, while
growing slowly, will be significant by the end of the century.240
While Congress has already been instrumental in bringing many of the
important issues to the forefront, it will undoubtedly be again called upon to
serve as a forum for debate and regulation. To address the problem, Con-
gress will have several options available. First, it could refuse to take any
action, thus allowing the courts and private parties to decide the issues
amongst themselves. This seems a highly unlikely course for Congress to
pursue, however, in light of its demonstrated interest and concern. Second,
it could encourage research and development by appropriating funds; a
somewhat unlikely course of action given its current zeal to reduce spending
for domestic programs. Third, genetic screening in the workplace could sim-
ply be banned. However, considering the advancements that have been
made and are expected, such action would seem precipitous, at best. How-
ever, if the costs of genetic testing were deemed to outweigh the benefits,
Congress might at least consider such prohibitions. Finally, Congress could
require establishment of regulations allowing research to continue but ensur-
ing that the important rights and duties that exist in industrial relations are
237. Omenn, supra note 56, at 373.
238. Samuels, supra note 3, at 576.
239. Appleson, supra note 245, at 1062-63.




It is anticipated that genetic screening will play an important role in the
area of employment testing. Genetic tests could have a significant impact on
minimizing incidents of occupational disease, and thus affect employers'
medical and legal expenses, decrease employer insurance costs and liabilities,
and lessen the burden on taxpayers. However, the potential benefits cannot
divert attention from such testing's serious legal ramifications. Genetic test-
ing in the workplace could infringe upon the privacy and confidentiality
rights of employers, discriminate against groups of "hypersusceptible" work-
ers, and relieve employers of their duty to maintain a safe workplace.
Notwithstanding these concerns, genetic tests have already been used absent
any guidelines or concern for its legal and ethical implications.
The benefits and costs of genetic testing demonstrate the need for legal
intervention, supervision and regulation. Because Congress has already be-
gun the process, there is strong support, particularly by labor unions, for its
continued presence in this new area of employment relations. Additionally,
while those concerned over the future of genetic employment testing are
searching for existing statutory protections, most have been found to be in-
adequate. Thus, it is expected that federal and state governments will need
to enact new legislation, or amend current statutes, to provide the proper
safeguards. Whatever authority ultimately asserts jurisdiction over genetic
testing, the primary objective is to design highly predictive tests and admin-
ister them by means of a nondiscriminatory system that offers effective legal,
social and economic protections to hypersusceptible workers and their
families.
Laura Rowinski
241. For a general discussion of these options see OTA Report, supra note 2, at 167-72.
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